SUFU and medulloblastoma: In conclusion, germline SUFU PV carriers have a life-long increased risk of tumours with a spectrum dominated by medulloblastoma before the age of 5 years, gonadal tumours during adolescence and BCC and meningioma in adulthood, justifying fine-tuned surveillance programmes, and the identification of healthy mutation carriers among relatives.